Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 55154-4384

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 55154-4384). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bag Label (91bfcdf6 7fef F49b E053 2995a90ade71 00)

Atorvastatin Calcium 80 mg film-coated tablets label showing a package containing 6 tablets. The label includes storage instructions, prescription only indication, manufacturer and distributor information, including Cardinal Health 107, LLC as the labeler. The label also displays the NDC 55154-4384 barcode and warnings related to child resistance and institutional use.*

FDA Label Image

Figure 1. Effect Of Atorvastatin Calcium 10 mg/day On Cumulative Incidence Of Nonfatal Myocardial Infarction Or Coronary Heart Disease Death (in Ascot-lla) (Ff26236c 3e07 44be A9be B619daf0ccb3 02)

A line graph depicting the cumulative incidence (%) over a period of 3.5 years, comparing Atorvastatin and Placebo groups. The graph includes hazard ratio (HR) data with confidence intervals and a p-value, illustrating the difference in incidence rates between the two groups over time.*

FDA Label Image

Figure 2. Effect Of Atorvastatin Calcium 10 mg/day On Time To Occurrence Of Major Cardiovascular Event (myocardial Infarction, Acute Chd Death, Unstable Angina, Coronary Revascularization Or Stroke) I (Ff26236c 3e07 44be A9be B619daf0ccb3 03)

A line graph depicting cumulative hazard percentages over time to a primary endpoint through four years of follow-up. Two curves compare Placebo (dashed line) and Atorvastatin (solid line), showing lower hazard in the Atorvastatin group across the study period. The hazard ratio and p-value are noted on the graph.*

FDA Label Image

Figure 3. Effect Of Atorvastatin Calcium 80 mg/day Vs. 10 mg/day On Time To Occurrence Of Major Cardiovascular Events (tnt) (Ff26236c 3e07 44be A9be B619daf0ccb3 04)

A Kaplan-Meier curve displaying the time to first major cardiovascular endpoint over 5 years for subjects receiving atorvastatin 10 mg versus 80 mg. The graph plots the percentage of subjects experiencing the event, showing separation of the curves with hazard ratio (HR) 0.78 (0.69-0.89) and p-value 0.0002, indicating statistical comparison of the two doses.*

FDA Label Image

Atorvastatin Calcium Structural Formula (Image 01)

Chemical structure of atorvastatin calcium, showing the molecular framework including calcium ions and associated water molecules, consistent with the atorvastatin calcium active ingredient in the drug product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.